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doi:10.1016/j.jmii.2011.12.006Background: Klebsiella pneumoniae liver abscess (KLA) is an emerging infectious disease
caused by the virulent K pneumoniae strains of capsular serotype K1 and commonly associated
with diabetes mellitus. Recurrent KLA is rarely reported and the mechanism of recurrence is
uncertain. In this study we evaluated both phagocytosis by neutrophils and serum killing ability
of serum from recurrent K1 KLA patients compared to normal healthy subjects (NHS).
Methods: This prospective study included six cases of recurrent K1 KLA consisting of three
male and three female patients with a mean age of 67.2 years (range, 56-88 years). The
different serotypes of K pneumoniae were reacted with serum from patients with recurrent
KLA and NHS. Subsequent phagocytosis by neutrophils was determined using flow cytometry
and serum killing assays were performed.
Results: The most common underlying disease in patients with recurrent KLA was diabetes
mellitus, occurring in about 83.3% (5/6) of patients. The antibiogram of the strains associated
with recurrent KLA remained uniquely resistant to ampicillin. The average percentage derived
from the serum killing assays showed serotype K1 and K2 resistance to serum from NHS (1281%
and 621%, respectively); however, serum susceptibly was observed in the serum of patients
with recurrent K1 KLA (0.3% and 1.1%, respectively). A significant increase in neutrophil phago-
cytosis of serotype K1 was observed following opsonisation with serum from patients withInfectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General
Road, Neihu 114, Taipei, Taiwan.
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142 F.-C. Yeh et al.recurrent KLA compared with serum from NHS (p Z 0.008). No significant difference in the
phagocytic rate of non-K1/K2 or K2 serotypes was observed between NHS and patients with
recurrent KLA (p Z 0.76 and p Z 0.132, respectively).
Conclusion: These preliminary results showed possible immunologic protection in patients with
recurrent KLA due to increasing opsonization and serum killing.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Pyogenic liver abscesses caused by K pneumoniae are an
emerging and common intra-abdominal infection. K pneu-
moniae has been identified as the predominant pathogen of
liver abscess in Taiwan.1e3 In the United States an
increasing incidence of K pneumoniae liver abscess (KLA) as
high as 41% has been observed. Among the 77 identified
capsular serotypes, K1 and K2 have been reported to play
a virulent role in K pneumoniae infection. Epidemiologic
studies have demonstrated that capsular serotypes K1 and
K2 are the most prevalent serotypes and are associated
with about 78% of liver abscess. Furthermore, diabetes
mellitus is a risk factor for KLA and is present in approxi-
mately 50e75% of patients with KLA.1,2,4e6 In previous
reports, patients with diabetes were shown to be more
susceptible to K pneumoniae infection due to the impair-
ment of opsonophagocytic and neutrophil functions.7,8 Poor
glycemic control also plays an important role in phagocytic
resistance of virulent K1/K2 K pneumoniae.
Recurrent KLA was very rare in English literature, and
only six patients with different serotypes isolated from
both primary and recurrent KLA have been reported.9 The
detailed mechanism involving recurrent KLA has not been
clarified. Nevertheless, production of humeral or cellular
immune responses targeted against infectious microorgan-
isms might be considered. The thesis of this study was to
demonstrate the possible immunologic protective reaction
in recurrent KLA. In this prospective study, six recurrent
KLA patients with confirmed K1 serotypes were enrolled to
compare clinical information with normal healthy subjects
(NHS) at Tri-Service General Hospital from 1996 to 2011.
Clinical information that was collected included bacterial
virulent factor genes rmpA/magA, serum killing, and
phagocytosis reactions.Materials and methods
Patient enrollment and bacterial isolates
We prospectively enrolled patients with liver abscesses and
traced their past history. K pneumoniae strains were iso-
lated from patients at Tri-Service General Hospital in
Taiwan from 1996 to 2011. Liver abscess was diagnosed by
clinical evaluation of the patient’s condition (e.g., fever,
chills), imaging studies (e.g., abdominal sonography,
computer tomography), and the presence of pathogen(s)
from an abscess or blood sample. Patients with a second
occurrence of KLA after completing treatment weredefined as recurrent KLA. Patients with relapse of liver
abscess due to insufficient treatment duration were
excluded and demographic data of patients were also
analyzed. All K pneumoniae strains were stored at -80C
before use. The study protocol was approved by the ethics
committees of our institutes and informed consent was
provided by all of the participants in the study.
K pneumoniae serotype determination
A total of 15 K pneumoniae strains with different capsular
serotypes were obtained from patients with primary liver
abscesses, patients with recurrent KLA, or from the Amer-
ican Type Culture Collection (Rockville, MD, USA). Sero-
typing was assessed by polymerase chain reaction (PCR) and
the capsular swelling technique.1 Nine strains of capsular
serotype K1 isolated from patients with recurrent KLA were
identified. Two strains of K1, two strains of K2, one strain of
non-K1/K2 (K38) obtained from clinical blood cultures, and
one strain of ATCC K47 were also used for the experiments
to exclude bacterial bias in the serum killing assay and
phagocytosis reaction.
Determination of the magA and rmpA genes
PCR was used to determine the prevalence of magA and
rmpA. Bacterial colonies were cultured overnight, added to
300 mL water and boiled for 15 min to release the DNA
template. Previously published primers were used for PCR:
magA forward 50-GGTGCTCTTTACATCATTGC-30, magA
reverse 50-GCAATGGCCATTTGCGTTAG-30, rmpA forward 50-
ACTGGGCTACCTCTGCTTCA-30, and rmpA reverse 50-
CTTGCATGAGCCATCTTTCA-30. The reaction mixture was
kept at 95C for 5 min; followed by 40 cycles of 95C for
1 min, 50C for 1 min, and 72C for 2 min; and a final
incubation at 72C for 7 min. The expected PCR products of
magA and rmpA were 1282 bp and 535 bp in length,
respectively.10
Phagocytosis reaction
Neutrophils from NHS without acute infection were sepa-
rated as previously described.11 Viability was shown to be
greater than 95% determined by trypan blue exclusion
assays. Human sera from 10 healthy volunteers without
acute infection or previous history of liver abscess as well
as sera from 6 patients with recurrent KLA were prepared.
Pooled NHS serum was obtained and stored in aliquots at
70C until required. To evaluate the serum effect of
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been not used due to insufficient humoral production in the
acute infection stage. Fluorescence (FITC) labeling of
2  108 cells of K pneumoniae per mL in phosphate buffer
solution (PBS) was performed as previously described and
stored at e70C prior to use. Phagocytosis was measured
using a standard assay.11 A FACScan (BD Biosciences,
Franklin Lakes, NJ, USA) was used to measure phagocytic
rates. Phagocytosis percentage was counted at 0, 30, and
60 minutes. A non-FITC-labeled tube served as the 0-minute
control. The experimental procedures and FACS settings
were performed as previously described.11
Serum killing assay
Serum resistance or susceptibility was assayed using
a modified method of Hughes and Podschun.12,13 Different
strains of K pneumoniae were reacted with sera from
patients with recurrent KLA as well as NHS. All experiments
were performed in triplicate. Bacteria grown in nutrient
broth were collected during the early logarithmic phase.
The viable bacterial concentration was adjusted to 1  106
colony forming units/mL and reacted with 75% pooled
human sera. A strain was considered serum resistant or
serum sensitive if the grading was the same in all experi-
ments. Each isolate was classified as highly sensitive (grade
1 or 2), intermediately sensitive (grade 3 or 4), or resistant
(grade 5 or 6). For grade 1, viable count (VC) after the 1st
and 2nd hour was <10% of the inoculum; after the third
hour, VC was <0.1%. For grade 2, the VC after the 1st hour
was 10e100%; after third hour, VC was <10%. For grade 3,
the VC after the 1st hour was >100% of inoculum; after the
2nd and 3rd hour VC was <100%. For grade 4, the VC after
the 1st and 2nd hour was >100%; after the 3rd hour the VC
was <100%. For grade 5, the VC after 1st, 2nd, and 3rd hour
was >100%, but the VC fell sometime during the 3-hour
period. For grade 6, the VC was >100% of the inoculum
after 1st, 2nd, and 3rd hour. Each strain was tested at least
three times.
Statistical analysis
Data was expressed as the mean  standard deviation (SD).
One-way analysis of variance (ANOVA) with repeated
measures was performed to compare the differences in
phagocytosis from 0 to 60 minutes between groups.
Student’s t-test was used to assess the differences in
phagocytosis rates at 60 minutes between groups. P values
<0.05 were considered statically significant.
Results
Patients
Six patients from 1996 to 2010 were identified with recur-
rent K1 KLA, including three male and three female
patients with a mean age of 67.2 years (range, 56e88
years). The average time between first occurrence and
recurrent liver abscess was 5.7 years (range, 0.33e20
years). The most common underlying diseases in thepatients with recurrent KLA were diabetes (83.3%, 5/6) and
hypertension (67%, 4/6). Gall stones, liver cirrhosis, and
peptic ulcer were also present in 18% (1/6) of these
patients. Poor glycemic control was observed in 80% (4/5)
of patients with recurrent KLA and hemoglobin A1c above
8.0% (average, 10.4%; range, 6.9e14.7%). The recurrent
KLA had been almost found in right lobe of liver. The
complication of metastasis, including brain abscess,
pulmonary embolism, and endophthalmitis was found in
16.7% (1/6) of patients with primary K1 KLA. There were no
metastatic complications observed in the patients with
recurrent KLA and bacteremia was observed in 50% of these
patients. A 100% survival rate without mortality was
observed in patients with recurrent KLA. The demographic
information and data gathered from patients are shown in
Table 1.
Serotype and virulent genes of recurrent KLA
Paired bacteria from primary and recurrent infections of
three patients with recurrent K1 KLA were isolated. The
other three patients with recurrent KLA had their primary
liver abscesses diagnosed at other hospitals. The antibio-
gram indicated that the primary and recurrent strains were
uniquely resistant to ampicillin. All primary and recurrent
strains were serotype K1 and harbored magA and rmpA
genes (Table 2).
Serum killing assays
The average percentage of serum killing showed serum
resistance of serotypes K1 and K2 when incubated with
serum from NHS (1281% and 621%, respectively). In
contrast, serum susceptibility was demonstrated when
these strains were incubated with serum from patients with
recurrent KLA (0.3% and 1.1%, respectively; Table 3).
However, there was no difference in percentage of serum
killing for non-K1/K2 strains between patients with recur-
rent KLA and NHS (0% and 0%, respectively).
Phagocytosis reaction
To evaluate the serum effect of patients with recurrent
KLA, we compared opsonization of different K pneumoniae
serotypes following incubation with serum from patients
with recurrent KLA and NHS. For opsonized non-K1/K2
isolates, phagocytosis rates between NHS and patients
with recurrent KLA were both similarly high, with 60-min
phagocytic uptake rates of 51.7  3.2% and 53.0  2.8%,
respectively. No significant difference in phagocytic rate of
non-K1/K2 isolates was observed between NHS and patients
with recurrent KLA (p Z 0.76; Fig. 1). For K2 isolates, the
phagocytosis rates between NHS and patients with recur-
rent KLA were also demonstrated to be similar, with 60-min
phagocytic uptake rates of 51.3  1.8% and 56.5  2.7%,
respectively (p Z 0.132; Fig. 2). In contrast, there was
a significantly increased phagocytosis rate for serotype K1
strains in patients with recurrent KLA compared to NHS,
with 60-min uptake rates of 54.0  2.3% versus 43.6  2.4%,
respectively (p Z 0.008; Fig. 3).
Table 1 Demographic data and clinical presentations of patients with recurrent serotype K1 K pneumoniae liver abscess (KLA)
Case1 Case 2 Case 3 Case 4 Case 5 Case 6
Sex/Age (y) M/62 F/58 M/88 M/56 F/58 F/81
Underlying Diseases Diabetes
Liver cirrhosis
Hypertension
Gastric ulcer Diabetes
Gallstones
HCVD
Diabetes
Hypertension
Diabetes
Hypertension
Diabetes
Hypertension
HgbA1c (%) 14.7 ND 9.2 6.9 13.7 7.4
Interval of onset (y) 7 2 3 20 2 0.33
1st abscess
size (cm) 5.8 8 3 Unknown 9.2 5
Site (segment) 4 4 6 Unknown 6&7 3&4&5
Bacteremia Yes Unknown No Unknown No No
Drainage No Yes No No Yes Yes
Complications Brain abscess
Endophthalmitis
Pulmonary emboli
None None None None None
Recurrent abscess
size (cm) 2 6.2 8 7.5 7.1 3.9
Site(segment) 6 6 6&7 8 6 8
Bacteremia Yes No No Yes No Yes
Drainage No Yes Yes Yes Yes Yes
Complication None None None None None None
Prognosis Survival Survival Survival Survival Survival Survival
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K pneumoniae has been identified as the predominant
bacteria responsible for community-acquired liver
abscesses in Taiwan and the United States.2,14 Epidemio-
logic studies have demonstrated that the capsular sero-
types K1 (64%) and K2 (14%) are the most prevalent in
community-acquired primary KLA and complicated metas-
tasis infections including endophthalmitis.3 Based on the
current literature, recurrent KLA has not been reported.
Previously, six patients with recurrent KLA (K1 and non-K1)
had been identified in our prospective study from 1996 to
2008. The predominant serotype in these patients was K1 at
about 84%. The most common underlying disease was dia-
betes mellitus, occurring in about 84% of these patients.
The focus in this current study was serotype K1 due to its
higher prevalence in patients with recurrent KLA. The
antibiogram of the strains isolated from patients withTable 2 Bacterial information of recurrent serotype K1 K pneu
Case1 Case 2 Case 3
1st isolate
Antibiogram
result
Ampicillin
resistance only
Ampicillin
resistance only
Ampicillin
resistance
magA Positive ND ND
rmpA Positive ND ND
2nd isolate
Antibiogram
result
Ampicillin
resistance only
Ampicillin
resistance only
Ampicillin
resistance
magA Positive Positive Positive
rmpA Positive Positive Positive
ND Z no datarecurrent K1 KLA remained uniquely resistant to ampicillin.
Bacteremia was found in 50% of the patients with recurrent
K1 KLA and there was no metastatic complications or
mortality in these patients. We suggest that diabetes mel-
litus, poor glycemic control, and the K1 serotype were still
common risk factors for recurrent KLA.
Among the 77 recognized capsular serotypes, K1 and K2
have been reported to have a clear relationship with
virulence and infection. Capsular serotypes K1 and K2 were
also the most prevalent when isolated from blood, sputum,
urine, pus, and liver abscess. Capsular antigens related to
antiphagocytosis and serum resistance to bactericidal
activity in K pneumoniae have been reported for clinical
infections. In both in vitro and in vivo studies, serotypes
K1 and K2 have been demonstrated to be more lethal.
Resistance of capsular serotypes K1 or K2 to phagocytosis
and intracellular killing presumably contributes to their
high prevalence in infections. Serum from patients withmoniae liver abscess (KLA)
Case 4 Case 5 Case 6
only
Ampicillin
resistance only
Ampicillin
resistance only
Ampicillin
resistance only
ND Positive Positive
ND Positive Positive
only
Ampicillin
resistance only
Ampicillin
resistance only
Ampicillin
resistance only
Positive Positive Positive
Positive Positive Positive
Table 3 Percentage of surviving K pneumoniae serotypes in serum killing assays from recurrent K pneumoniae liver abscess
(KLA) and normal healthy subjects (NHS)
0 hour 1 hour (%) 2 hour (%) 3 hour (%)
(NHS)
K1 32  105 10  106 (323) 20  106 (625) 41  106 (1281)
K2 37  105 11  106 (297) 34  106 (930) 23  106 (621)
Non-K1/K2 22  105 14  105 (64) 2  105 (9) 0 (0)
(patient)
K1 32  105 13  104 (4) 5  104 (1.6) 1  104 (0.3)
K2 38  105 17  104 (4.5) 7  104 (1.8) 4  104 (1.1)
Non-K1/K2 29  105 7  104 (2.4) 0 (0) 0 (0)
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oposonization of neutrophils to phagocytose with higher
anti-phagocytosis and serum resistance of capsular sero-
type K1.
Considering the antibiogram analysis of strains from
patients with recurrent KLA, the unique characteristic of
ampicillin resistance was found for both primary and
recurrent KLA. In a previous study of KLA in Taiwan,
community-acquired KLA with a unique antibiogram indic-
ative of resistance only to ampicillin was discovered. There
was no difference in the antibiogram among primary,
recurrent, and community-acquired KLA. The drug sensi-
tivity tests of the K pneumoniae strains isolated from
patients with recurrent K1 KLA were all susceptible to
nearly all antibiotics except ampicillin.1,4,5 There were no
instances of distant metastasis in the patients with recur-
rent KLA from this study possibly because they had received
early treatment by broad spectrum antibiotics due to
suspicion of liver abscess as a result of previous KLA. All
patients in this study received antibiotic treatment and
drainage without mortality or morbidity and all recovered
completely. Adequate antibiotic treatment and early
drainage were the main treatment for patients with KLA.
Six independent factors, including; normal platelet count,
alkaline phosphatase less than 300 U/liter, no gas formationFigure 1. Comparison of neutrophil phagocytosis with sero-
type non-K1/K2 K pneumoniae by oposonization of recurrent K
pneumoniae liver abscess (KLA) and normal healthy subjects
(NHS) (p Z 0.765).in the abscess, an APACHE III score less than 40, use of
extended-spectrum cephalosporin, and early drainage were
good predictors against severe complications in patients
with KLA.15
KLA is common in Taiwan but recurrence is very rare in
clinical practice.1e3 To date, the pathogenesis of liver
abscesses is not completely understood. However, previous
studies have noted that diabetes mellitus is correlated to
a high KLA prevalence rate (78%), especially with the
additional complication of septic endophthalmitis.16 Among
patients with distant metastasis to septic endophthalmitis,
92% also had diabetes. Poor neutrophil function and
impairment of opsonophagocytic function were noted in
patients with diabetes and poor glycemic control.7,8 In our
patients, five were diabetic with poor glycemic control and
high hemoglobin A1c. We assumed that diabetes mellitus
was also a risk factor for recurrence which may explain why
patients with diabetes were more susceptible to KLA and
recurrent KLA.
Previous reports have shown that recurrent liver
abscesses are rare and are mostly related to granulomatous
disease,17e19 immunocompromised diseases,18,20 and ame-
bic infections.21,22 The rate of amebic liver abscess recur-
rence is lower than 0.04% per year and the recurrence of
KLA has rarely been reported.9 The specific adaptiveFigure 2. Comparison of neutrophil phagocytosis with sero-
type K2 K pneumoniae by oposonization of recurrent K pneu-
moniae liver abscess (KLA) and normal healthy subjects (NHS)
(p Z 0.132).
Figure 3. Comparison of neutrophil phagocytosis with sero-
type K1 K pneumoniae by oposonization of recurrent K pneu-
moniae liver abscess (KLA) and normal healthy subjects (NHS)
(p Z 0.008).
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antigens. Immunoglobulin can be induced after attacking
the KLA. The protection of the host with a specific immune
response has been considered. A significant increase in
neutrophil phagocytosis of serotypes K1 K pneumoniae
opsonized with serum from patients with recurrent KLA was
observed when compared with serum from NHS. These
results might explain why a low incidence of recurrent K1
KLA is observed. The possibility of recurrence has been
thought to be related to inadequate treatment, immuno-
logical incompetence, and repeated exposure to infectious
organisms.21 The exact relationship between the environ-
ment and host still requires more clarification. The limita-
tions of our study included the limited number of patients,
lack of serum component analysis, and a lack of protein
qualification. The detailed mechanism involved in recur-
rent KLA still requires further clarification.
In conclusion, our results showed increasing opsoniza-
tion and serum killing in patients with recurrent K1 KLA.
Although patients with recurrent K1 KLA were commonly
diabetic with poor glycemic control, they might have higher
immunologic protection against K1 strains after primary
KLA. Further studies to link the recurrence of liver abscess
and enhanced immunological response are needed.
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